Contents

Current Rheumatology Reviews, Volume 5 - Number 3

Editorial [Hot topic: Utilization of Biology Therapy in Spondyloarthropathy (SpA) in Asia Countries (Guest Editor: Chung-Tei Chou)]

, 5(3): 148

Chung-Tei Chou


DOI: 10.2174/157339709789208633




The Use of Biologics for Psoriasis in Asia-Pacific Region

, 5(3): 149 - 152

Tsen-Fang Tsai and Ting-Yu Yeh


DOI: 10.2174/157339709789208615




Other Future Targeting Therapy Beyond TNF-α Inhibitor in Patients with Spondyloarthropathy

, 5(3): 153 - 157

Wen-Chan Tsai, Tsang-Teng Ou and Chen-Ching Wu


DOI: 10.2174/157339709789208624




Anti Tumor Necrosis Factor Alpha (TNFα) Therapy in Ankylosing Spondylitis - Asian Perspective

, 5(3): 158 - 164

Tsz Yan Lee and Feng Huang


DOI: 10.2174/157339709789208651




Which Biomarker is Useful to Evaluate as a Treatment Outcome in Spondyloarthritis?

, 5(3): 165 - 168

Sang-Hoon Lee and Tae Hwan Kim


DOI: 10.2174/157339709789208679




Early Diagnosis of AS or Other SpA - From Clinical and Radiologic Viewpoint

, 5(3): 169 - 173

Ashok Kumar and Chandan J. Das


DOI: 10.2174/157339709789208660




Anti-Tumor Necrosis Factor-α Therapy in Undifferentiated Spondyloarthritis (USpA)

, 5(3): 174 - 176

Hsien-Tzung Liao, Chun-Hsiung Chen, Wei-Sheng Chen, Hui-Ting Lee, Chang-Youh Tsai and Chung-Tei Chou


DOI: 10.2174/157339709789208642




Demographic Characteristic of Ankylosing Spondylitis in Chinese

, 5(3): 177 - 181

Chun-Hsiung Chen, Hung-An Chen, Hsien-Tzung Liao, Chin-Hsiu Liu, Toong-Hua Liang, Chang-Youh Tsai and Chung-Tei Chou


DOI: 10.2174/157339709789208697




The Characteristic of Histopathology in Spondyloarthropathy

, 5(3): 182 - 185

Wei-Sheng Chen, Chang-Youh Tsai and Chung-Tei Chou


DOI: 10.2174/157339709789208688




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science